Spontaneous ADR Reports as a Trigger for Pharmacogenetic Research: A Prospective Observational Study in the Netherlands

By >  

Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite

Risk Management and Outcomes of Adverse Events to Pioglitazone in Primary Care in the UK: An Observational Study

By Fogg Carole   Kasliwal Rachna   Shakir Saad A.W.  

Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. : 229-237

Adis International

Access to resources Recommend Favorite

Pioglitazone Lowers Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus: An Open, Multicentre, Observational Study

By Konrad Thomas   Lübben Georg   Franzen Christine  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 337-340

Adis International

Access to resources Recommend Favorite

Pioglitazone: side effect and safety profile

By Shah Priya   Mudaliar Sunder  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 347-354

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone

By Gillies P.S.   Dunn C.J.  

Drugs, Vol. 60, Iss. 2, 2000-08 ,pp. : 333-343

Adis International

Access to resources Recommend Favorite